List of works - Baptist Gallwitz

11beta-hydroxysteroid dehydrogenase 2 activity is elevated in severe obesity and negatively associated with insulin sensitivity

scientific article published on 10 April 2008

17alpha-hydroxylase/17,20-lyase deficiency caused by a novel homozygous mutation (Y27Stop) in the cytochrome CYP17 gene

scientific article published on 5 April 2005

A novel MR-imaging technique using arterial spin labeling for thyroid gland perfusion in thyrotoxicosis

scientific article published on 01 November 2007

Association of type 2 diabetes candidate polymorphisms in KCNQ1 with incretin and insulin secretion

scientific article published on 14 April 2009

Common polymorphisms within the NR4A3 locus, encoding the orphan nuclear receptor Nor-1, are associated with enhanced beta-cell function in non-diabetic subjects

scientific article published on 14 August 2009

Considering Insulin Secretory Capacity as Measured by a Fasting C-Peptide/Glucose Ratio in Selecting Glucose-Lowering Medications

scientific article published on 18 September 2020

DPP4 gene variation affects GLP-1 secretion, insulin secretion, and glucose tolerance in humans with high body adiposity

scientific article published on 27 July 2017

Deteriorated executive functions in patients with successful surgery for pituitary adenomas compared with other chronically ill patients

scientific article published on 21 December 2010

Dissociation of GLP-1 and insulin association with food processing in the brain: GLP-1 sensitivity despite insulin resistance in obese humans

scientific article published on 30 September 2015

Effects of intravenous glucagon-like peptide-1 on glucose control and hemodynamics after coronary artery bypass surgery in patients with type 2 diabetes

scientific article published in September 2008

Emerging DPP-4 inhibitors: focus on linagliptin for type 2 diabetes ⬇️

scientific article published on January 4, 2013

Gastric inhibitory polypeptide: the neglected incretin revisited

scientific article

Glucagon-like peptide 1 and gastric inhibitory polypeptide: potential applications in type 2 diabetes mellitus

scientific article

Glucagon-like peptide 1 as a regulator of food intake and body weight: therapeutic perspectives

scientific article

Glucagon-like peptide-1-based therapies for the treatment of type 2 diabetes mellitus

scientific article

Hashimoto's encephalopathy presenting with bipolar affective disorder

scientific article published in June 2005

Ileus of uncommon cause--important and weighty facts

scientific article

Implications of postprandial glucose and weight control in people with type 2 diabetes: understanding and implementing the International Diabetes Federation guidelines

scientific article

Increased occurrence of weaknesses in attention testing in patients with Hashimoto's thyroiditis compared to patients with other thyroid illnesses

scientific article published on 25 September 2008

Increased prevalence of antibodies to central nervous system tissue and gangliosides in Hashimoto's thyroiditis compared to other thyroid illnesses

scientific article

Influence of gastric inhibitory polypeptide on pentagastrin-stimulated gastric acid secretion in patients with type 2 diabetes and healthy controls

scientific article

Intravenous glucagon-like peptide 1 normalizes blood glucose after major surgery in patients with type 2 diabetes

scientific article

Iodine-induced thyrotoxicosis after ingestion of kelp-containing tea.

scientific article published in June 2006

Low performance in attention testing is associated with reduced grey matter density of the left inferior frontal gyrus in euthyroid patients with Hashimoto’s thyroiditis ⬇️

scientific article published on September 23, 2012

Manifestation of thyroid autoimmunity in patients successfully treated for hypercortisolism

scientific article

Nonsuppressed Glucagon After Glucose Challenge as a Potential Predictor for Glucose Tolerance

scientific article

Pheochromocytoma in a patient with sickle-beta-thalassemia

scientific article published in August 2005

Preclinical and Clinical Data on Extraglycemic Effects of GLP-1 Receptor Agonists

scientific article

Preliminary report: genetic variation within the GPBAR1 gene is not associated with metabolic traits in white subjects at an increased risk for type 2 diabetes mellitus

scientific article published on 28 August 2009

Review of sitagliptin phosphate: a novel treatment for type 2 diabetes

scientific article published on January 2007

Safety and efficacy of insulin detemir basal-bolus therapy in type 1 diabetes patients: 14-week data from the European cohort of the PREDICTIVE study

scientific article

Safety and efficacy of linagliptin in type 2 diabetes patients with common renal and cardiovascular risk factors ⬇️

scientific article published on June 1, 2013

Saxagliptin, a dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes

scientific article published on December 2008

Sitagliptin: Profile of a novel DPP-4 inhibitor for the treatment of type 2 diabetes

scientific article published on January 2007

Sitagliptin: profile of a novel DPP-4 inhibitor for the treatment of type 2 diabetes (update).

scientific article

Somatostatin receptor expression in a parathyroid hormone-related peptide-secreting pancreatic neuroendocrine tumour causing severe hypercalcaemia

scientific article published on 01 August 2007

The continuing need for drug development and clinical trials in type 2 diabetes and its complications: introduction to the RDS special issue

scientific article published on 10 November 2011

The development of the Tuebingen Cushing’s disease quality of life inventory (Tuebingen CD‐25). Part II: normative data from 1784 healthy people ⬇️

scientific article published on June 1, 2012

The evolving place of incretin-based therapies in type 2 diabetes

scientific article

The fate of Beta-cells in type 2 diabetes and the possible role of pharmacological interventions

scientific article published on January 2006

The inhibitory effect of recent type 2 diabetes risk loci on insulin secretion is modulated by insulin sensitivity

scientific article published on 3 March 2009

Thyroid peroxidase antibody positivity is associated with symptomatic distress in patients with Hashimoto's thyroiditis

scientific article published on 21 January 2012

Variation in the CDKAL1 gene is associated with the titer of antibodies to GAD

scientific article published on 01 September 2008

Younger age is a good predictor of better executive function after surgery for pituitary adenoma in adults

scientific article published on 29 July 2009

List of works by Baptist Gallwitz

11beta-hydroxysteroid dehydrogenase 2 activity is elevated in severe obesity and negatively associated with insulin sensitivity

17alpha-hydroxylase/17,20-lyase deficiency caused by a novel homozygous mutation (Y27Stop) in the cytochrome CYP17 gene

A novel MR-imaging technique using arterial spin labeling for thyroid gland perfusion in thyrotoxicosis

Association of type 2 diabetes candidate polymorphisms in KCNQ1 with incretin and insulin secretion

Common polymorphisms within the NR4A3 locus, encoding the orphan nuclear receptor Nor-1, are associated with enhanced beta-cell function in non-diabetic subjects

Considering Insulin Secretory Capacity as Measured by a Fasting C-Peptide/Glucose Ratio in Selecting Glucose-Lowering Medications

DPP4 gene variation affects GLP-1 secretion, insulin secretion, and glucose tolerance in humans with high body adiposity

Deteriorated executive functions in patients with successful surgery for pituitary adenomas compared with other chronically ill patients

Dissociation of GLP-1 and insulin association with food processing in the brain: GLP-1 sensitivity despite insulin resistance in obese humans

Effects of intravenous glucagon-like peptide-1 on glucose control and hemodynamics after coronary artery bypass surgery in patients with type 2 diabetes

Emerging DPP-4 inhibitors: focus on linagliptin for type 2 diabetes ⬇️

Gastric inhibitory polypeptide: the neglected incretin revisited

Glucagon-like peptide 1 and gastric inhibitory polypeptide: potential applications in type 2 diabetes mellitus

Glucagon-like peptide 1 as a regulator of food intake and body weight: therapeutic perspectives

Glucagon-like peptide-1-based therapies for the treatment of type 2 diabetes mellitus

Hashimoto's encephalopathy presenting with bipolar affective disorder

Ileus of uncommon cause--important and weighty facts

Implications of postprandial glucose and weight control in people with type 2 diabetes: understanding and implementing the International Diabetes Federation guidelines

Increased occurrence of weaknesses in attention testing in patients with Hashimoto's thyroiditis compared to patients with other thyroid illnesses

Increased prevalence of antibodies to central nervous system tissue and gangliosides in Hashimoto's thyroiditis compared to other thyroid illnesses

Influence of gastric inhibitory polypeptide on pentagastrin-stimulated gastric acid secretion in patients with type 2 diabetes and healthy controls

Intravenous glucagon-like peptide 1 normalizes blood glucose after major surgery in patients with type 2 diabetes

Iodine-induced thyrotoxicosis after ingestion of kelp-containing tea.

Low performance in attention testing is associated with reduced grey matter density of the left inferior frontal gyrus in euthyroid patients with Hashimoto’s thyroiditis ⬇️

Manifestation of thyroid autoimmunity in patients successfully treated for hypercortisolism

Nonsuppressed Glucagon After Glucose Challenge as a Potential Predictor for Glucose Tolerance

Pheochromocytoma in a patient with sickle-beta-thalassemia

Preclinical and Clinical Data on Extraglycemic Effects of GLP-1 Receptor Agonists

Preliminary report: genetic variation within the GPBAR1 gene is not associated with metabolic traits in white subjects at an increased risk for type 2 diabetes mellitus

Review of sitagliptin phosphate: a novel treatment for type 2 diabetes

Safety and efficacy of insulin detemir basal-bolus therapy in type 1 diabetes patients: 14-week data from the European cohort of the PREDICTIVE study

Safety and efficacy of linagliptin in type 2 diabetes patients with common renal and cardiovascular risk factors ⬇️

Saxagliptin, a dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes

Sitagliptin: Profile of a novel DPP-4 inhibitor for the treatment of type 2 diabetes

Sitagliptin: profile of a novel DPP-4 inhibitor for the treatment of type 2 diabetes (update).

Somatostatin receptor expression in a parathyroid hormone-related peptide-secreting pancreatic neuroendocrine tumour causing severe hypercalcaemia

The continuing need for drug development and clinical trials in type 2 diabetes and its complications: introduction to the RDS special issue

The development of the Tuebingen Cushing’s disease quality of life inventory (Tuebingen CD‐25). Part II: normative data from 1784 healthy people ⬇️

The evolving place of incretin-based therapies in type 2 diabetes

The fate of Beta-cells in type 2 diabetes and the possible role of pharmacological interventions

The inhibitory effect of recent type 2 diabetes risk loci on insulin secretion is modulated by insulin sensitivity

Thyroid peroxidase antibody positivity is associated with symptomatic distress in patients with Hashimoto's thyroiditis

Variation in the CDKAL1 gene is associated with the titer of antibodies to GAD

Younger age is a good predictor of better executive function after surgery for pituitary adenoma in adults